21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer

被引：0
|
作者：
Gulisa Turashvili
Joanne F. Chou
Edi Brogi
Monica Morrow
Maura Dickler
Larry Norton
Clifford Hudis
Hannah Y. Wen
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Pathology
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
[3] Memorial Sloan Kettering Cancer Center,Department of Surgery
[4] Memorial Sloan Kettering Cancer Center,Department of Medicine
来源：
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词：
Breast cancer; 21-Gene recurrence score assay; Recurrence score; Locoregional recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：69 / 76
页数：7
相关论文
共 50 条
  • [1] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Turashvili, Gulisa
    Chou, Joanne F.
    Brogi, Edi
    Morrow, Monica
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 69 - 76
  • [2] Predictive value of 21-gene recurrence score assay in non-estrogen receptor-positive and lymph node-negative breast cancer
    Lu, Kai
    Li, Hui
    Wu, Zhaoshu
    Liu, Dong
    Ye, Hongling
    Xu, Liang
    Liu, Yanwen
    [J]. JOURNAL OF BUON, 2018, 23 (05): : 1297 - 1301
  • [3] Clinical significance of 21-gene recurrence score assay for hormone receptor-positive, lymph node-negative breast cancer in early stage
    Yang Yu-qing
    Wang Lei
    Huang Mei-ling
    Xiao Jing-jing
    Wei Mei-chen
    Wu Jiang
    Hao Jun-sheng
    Ling Rui
    Li Nan-lin
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 150 - 155
  • [4] Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer
    Minji Koh
    Jinhong Jung
    Su Ssan Kim
    Seung Do Ahn
    Eun Kyung Choi
    Il Yong Chung
    Jong Won Lee
    Sung-Bae Kim
    Jae Ho Jeong
    [J]. Breast Cancer Research and Treatment, 2021, 188 : 583 - 592
  • [5] Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer
    Koh, Minji
    Jung, Jinhong
    Kim, Su Ssan
    Do Ahn, Seung
    Choi, Eun Kyung
    Chung, Il Yong
    Lee, Jong Won
    Kim, Sung-Bae
    Jeong, Jae Ho
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (03) : 583 - 592
  • [6] Effect of 21-Gene Recurrence Score Results on Treatment Recommendations in Patients with Lymph Node-Positive, Estrogen Receptor-Positive Breast Cancer
    Oratz, R.
    Chao, C.
    Skrzypczak, S.
    Kim, B.
    Broder, M.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 602S - 602S
  • [7] 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer
    Kizy, Scott
    Altman, Ariella M.
    Marmor, Schelomo
    Denbo, Jason W.
    Jensen, Eric H.
    Tuttle, Todd M.
    Hui, Jane Yuet Ching
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (02) : 322 - 329
  • [8] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Jessica F. Partin
    Eleftherios P. Mamounas
    [J]. Annals of Surgical Oncology, 2011, 18 : 3399 - 3406
  • [9] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Partin, Jessica F.
    Mamounas, Eleftherios P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (12) : 3399 - 3406
  • [10] Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
    Mamounas, Eleftherios P.
    Tang, Gong
    Fisher, Bernard
    Paik, Soonmyung
    Shak, Steven
    Costantino, Joseph P.
    Watson, Drew
    Geyer, Charles E., Jr.
    Wickerham, D. Lawrence
    Wolmark, Norman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1677 - 1683
12345